Method of detecting β-lactam antibiotic induced vancomycin resistant MRSA (BIVR)

Despite the fact that the combination of vancomycin and a β-lactam antibiotic are known to act synergistically on vancomycin-susceptible Staphylococcus aureus (VSSA), some MRSA have emerged showing antagonism to the combination of vancomycin and a β-lactam antibiotic. These MRSA are called β-lactam...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of antimicrobial agents Vol. 23; no. 1; pp. 1 - 5
Main Authors Hanaki, Hideaki, Yamaguchi, Yoshio, Nomura, Syuichi, Haraga, Isao, Nagayama, Ariaki, Sunakawa, Keisuke
Format Journal Article
LanguageEnglish
Published London Elsevier B.V 2004
Amsterdam Elsevier
New York, NY
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Despite the fact that the combination of vancomycin and a β-lactam antibiotic are known to act synergistically on vancomycin-susceptible Staphylococcus aureus (VSSA), some MRSA have emerged showing antagonism to the combination of vancomycin and a β-lactam antibiotic. These MRSA are called β-lactam antibiotic-induced vancomycin resistant MRSA (BIVR). A method based on this antagonistic phenomenon has been devised to detect BIVR strains. The method inhibits the VSSA strain but allows the BIVR strain to grow. Forty-six commercially available β-lactam antibiotics induced the vancomycin-resistance. Using this detection method, 717 MRSA clinical isolates obtained from eight institutes throughout Japan were thus screened and 6.3% of these were detected as BIVR when judged at 48 h.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0924-8579
1872-7913
DOI:10.1016/j.ijantimicag.2003.05.018